HUAWEI WEARABLES CITED IN CARDIOVASCULAR HEALTH RESEARCH

TechnologyWearablesHUAWEI WEARABLES CITED IN CARDIOVASCULAR HEALTH RESEARCH

HUAWEI WATCH GT 7 Series and HUAWEI WATCH D3 take the spotlight at two international medical conferences on cardiovascular health and blood pressure monitoring

HUAWEI is advancing its contributions to cardiovascular health research, with studies involving its wearable devices gaining recognition at two international medical conferences: the 19th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in South Korea, and the 31st International Society of Hypertension Scientific Meeting and 17th Emirates Cardiac Society Annual Conference (ISH-ECS) in Dubai.

At ISH-ECS 2026, HUAWEI also showcased its latest blood pressure monitoring innovations, including the HUAWEI WATCH D3, and highlighted its collaboration with the ISH through the newly established Wearable Blood Pressure Technology Innovation Fund.

Together, these developments reflect HUAWEI’s efforts to bridge medical research and consumer technology, bringing cardiovascular monitoring capabilities closer to everyday users. Through the HUAWEI WATCH GT 7 Pro and WATCH D3, the brand aims to make heart health and blood pressure monitoring more accessible while supporting greater awareness of cardiovascular health.

RESEARCH AT APHRS 2026

HUAWEI WATCH D3

At APHRS 2026, research involving HUAWEI wearables was cited in the 2026 Asia Pacific Atrial Fibrillation Guidelines. HUAWEI says this highlights the potential of its wearables in clinical settings and the growing role of smart devices in supporting proactive heart health monitoring.

The study explored the links between sleep apnea, arrhythmia, blood pressure, and cardiovascular events using data from HUAWEI devices. HUAWEI notes that research findings are based on the specific study population and methodology and should not be read as establishing causation or guaranteeing individual health outcomes.

BLOOD PRESSURE MONITORING AT ISH-ECS 2026

At ISH-ECS 2026, HUAWEI showcased its latest advancements in blood pressure monitoring in collaboration with the ISH through the Wearable Blood Pressure Technology Innovation Fund.

HUAWEI introduced its Minimally Disruptive Ambulatory Blood Pressure Monitoring (ABPM) research initiative at the conference. Developed in partnership with Ruijin Hospital, the study explores a hybrid approach that combines continuous photoplethysmography (PPG) monitoring with airbag-based blood pressure measurements. The goal is to reduce reliance on cuff-based readings and make long-term blood pressure monitoring more comfortable and practical for users.

“Innovations like Minimally Disruptive ABPM and environmental monitoring reminders by HUAWEI Watch D3 may be inspiring for shaping a new direction on how future blood pressure management is automated and seamlessly embedded into daily life, via wearable devices,” said Chinese Hypertension Association president Wang Jiguang.

HEALTH TRACKING ON THE WATCH D3 AND GT 7 PRO

HUAWEI WATCH D3

The HUAWEI WATCH D3 and GT 7 Pro feature a one-tap Health Glance assessment that analyzes indicators such as heart rate, heart rate variability (HRV), blood oxygen levels, arterial elasticity, and ECG data in seconds. The watch combines these metrics to generate a report, helping users understand their overall health and spot potential risks early.

HUAWEI notes that these features are not a medical device. All monitoring data and results are for reference and general health or wellness only, and should not be used as a basis for medical diagnosis, prevention, monitoring, prediction, or treatment. Product features and availability may vary by country or region.

From early risk detection to continuous long-term management, HUAWEI says it remains committed to using smart technology to advance health awareness. By collaborating with global medical and research partners, the brand aims to innovate digital health solutions and make heart and blood pressure care more accessible.

To learn more, visit HUAWEI’s official website or social media accounts: Facebook and Instagram.

Related Posts